This must be the first visit for Amarantus to this particular ( Noble Financial) conference. Nowhere can I find a pr stating otherwise...
Interestingly, if GC and company stick around for the sessions on the 20th there is a NASDAQ rep ( Andrew Hall-Managing Director new listings at NASDAQ) slotted in as one of the panelists...

Quote:

---

5:00pm - 6:30pm - Attracting Strategic Financing - Listing on an Exchange Panel / Wine & Cheese Reception
- Conference Concourse, Room 5 - Spanish Patio


The panel discussion will focus on successful strategies and tactics for strategic financing, partnering and acquisition (for both private and public companies) with pharma, as well as positioning companies for becoming publically traded or uplisting onto an exchange like NASDAQ in order to maximize shareholder value.

Confirmed Panelists:



Jules Musing (formerly Global Head of Biotechnology Licensing and Business Development, and for global Drug Licensing at Johnson & Johnson, NLSP SAB Chairman)



Victor Hartman MD (Former head of Corporate and Strategic Development at Vertex Pharmaceuticals, NLSP SAB member)



Steven Glover (CEO of Variant Pharmaceuticals)


Michael Lerner JD (Chair of Lowenstein Sandler Life Sciences Group)

Andrew Hall (Managing Director, New Listings at NASDAQ)


Moderator: Shawn Titcomb (NLSP, Managing Director, Head of Investment / Merchant Banking)

---